DRUG · Unmapped registry intervention
Recombinant oncolytic herpes simplex virus type 1 (R130)
Find medicine records ·
Find other trials using this name
Clinical trial
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
NCT05860374
Study summary
ClinicalTrials.govA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: EARLY_PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Sarcomaverified · MONDO: sarcoma
Carcinomaverified · MONDO: carcinoma
Breast Cancerverified · MONDO: breast cancer
Colorectal Cancerverified · MONDO: colorectal cancer
Gastric Cancerverified · MONDO: gastric cancer
Liver Cancerverified · MONDO: liver cancer
Lung Cancerverified · MONDO: lung cancer
Interventions
Sponsors & collaborators
Shanghai Yunying Medical Technologylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05860374 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.